FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hartmut Lode

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Hartmut Lode; Ralf Stahlmann
[Antibiotics - quo vadit?].
Hartmut Lode; A Razmpour; B Schmoele-Thoma; G Siber; T Welte; N Ahlers; S Baker; Olaf Burkhardt; P Fernsten; William C Gruber; Jill Hackell; Stephen Lockhart; Andres De Roux
Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1 ×, 2 ×, or 4 ×) in healthy subjects aged 70 years or older.
Hartmut Lode
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hartmut Lode (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Hartmut Lode; Ralf Stahlmann
[Antibiotics - quo vadit?].
Deutsche medizinische Wochenschrift (1946) 2012;137(24):1314-6.
2011: Hartmut Lode; A Razmpour; B Schmoele-Thoma; G Siber; T Welte; N Ahlers; S Baker; Olaf Burkhardt; P Fernsten; William C Gruber; Jill Hackell; Stephen Lockhart; Andres De Roux
Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1 ×, 2 ×, or 4 ×) in healthy subjects aged 70 years or older.
Vaccine 2011;29(31):4940-6.
2010: Hartmut Lode
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections.
The American journal of medicine 2010;123(4 Suppl):S26-38.
2010: Judith Sendzik; Mehdi Shakibaei; Monika Schäfer-Korting; Hartmut Lode; Ralf Stahlmann
Synergistic effects of dexamethasone and quinolones on human-derived tendon cells.
International journal of antimicrobial agents 2010;35(4):366-74.
2010: Ralf Stahlmann; Hartmut Lode
Safety considerations of fluoroquinolones in the elderly: an update.
Drugs & aging 2010;27(3):193-209.
2009: Hartmut Lode
Clinical impact of antibiotic-resistant Gram-positive pathogens.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15(3):212-7.
2009: Judith Sendzik; Hartmut Lode; Ralf Stahlmann
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data.
International journal of antimicrobial agents 2009;33(3):194-200.
2008: M Eisenblätter; C Klaus; M W R Pletz; H Orawa; H Hahn; J Wagner; Hartmut Lode
Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(11):1087-92.
2008: Mathias Pletz; Ulrich Maus; Norbert Krug; Tobias Welte; Hartmut Lode
Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
International journal of antimicrobial agents 2008;32(3):199-206.
2008: Hartmut Lode
Rational antibiotic therapy and the position of ampicillin/sulbactam.
International journal of antimicrobial agents 2008;32(1):10-28.
2008: Antoni Torres; Javier Garau; Pierre Arvis; Jean Carlet; Shurjeel Choudhri; Amar Kureishi; Marie-Aude Le Berre; Hartmut Lode; John Winter; Robert C Read
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(10):1499-509.
2008: Hartmut Lode; Malina Schmidt-Ionas; Ralf Stahlmann
Gemifloxacin for community-acquired pneumonia.
Expert opinion on investigational drugs 2008;17(5):779-86.
2008: Andrés de Roux; B Schmöle-Thoma; B Schmöele-Thoma; G R Siber; J G Hackell; A Kuhnke; N Ahlers; S A Baker; A Razmpour; E A Emini; P D Fernsten; W C Gruber; Stephen Lockhart; O Burkhardt; Tobias Welte; Hartmut Lode
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(7):1015-23.
2008: Hartmut Lode
Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. Introduction.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2008;14 Suppl 3():1-2.
2008: Mathias Pletz; U Maus; Jens Hohlfeld; Hartmut Lode; Tobias Welte
[Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
Deutsche medizinische Wochenschrift (1946) 2008;133(8):358-62.
2008: S R Ott; M Allewelt; J Lorenz; P Reimnitz; Hartmut Lode
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.
Infection 2008;36(1):23-30.
2007: Hartmut Lode; Antoni Torres; A Cockle
[What are the reasons for our choice? Proofs, recommendations or habit?].
Médecine et maladies infectieuses 2007;37 Spec No 1():17-22.
2007: keith klugman; Hartmut Lode
[Complex choices in respiratory tract infections: the search for simple solutions].
Médecine et maladies infectieuses 2007;37 Spec No 1():1.
2007: Hartmut Lode
Managing community-acquired pneumonia: a European perspective.
Respiratory medicine 2007;101(9):1864-73.
2007: Robert G Masterton; Donald E Craven; jordi rello; Marc Jean Struelens; N Frimodt-Moller; Jean Chastre; A Ortqvist; Giuseppe Cornaglia; Hartmut Lode; Helen Giamarellou; Marc J M Bonten; H Eraksoy; P Davey
Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development.
The Journal of antimicrobial chemotherapy 2007;60(2):206-13.
2007: Hartmut Lode; Markus Allewelt; S Balk; Andres De Roux; Harald Mauch; Michael S Niederman; Malina Schmidt-Ioanas
A prediction model for bacterial etiology in acute exacerbations of COPD.
Infection 2007;35(3):143-9.
2007: Hartmut Lode; Jutta Wagner; Hans Scherübl
The impersonator.
The American journal of medicine 2007;120(3):239-41.
2007: Hartmut Lode; Antoni Torres; Antony Cockle
What drives our choices? Evidence, guidelines or habit?
International journal of antimicrobial agents 2007;29 Suppl 1():S17-22.
2007: Olaf Burkhardt; Hartmut Lode; Tobias Welte; Hans-Joachim Merker
Ultrastructural types of alveolar macrophages in bronchoalveolar lavages from patients with pulmonary sarcoidosis.
Micron (Oxford, England : 1993) 2007;38(6):572-9.
2006: Hartmut Lode; Ralf Stahlmann; Heino Skopnik
[Rational use of oral antibiotics in adults and school children (children above 6 years). Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy. V].
Medizinische Monatsschrift für Pharmazeuten 2006;29(12):441-55.
2006: Rafael Cantón; Hartmut Lode; Wolfgang Graninger; Gary Milkovich
Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
International journal of antimicrobial agents 2006;28 Suppl 2():S115-27.
2006: T Blum; A Roth; Harald Mauch; R Erbes; Hartmut Lode
[Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series].
Deutsche medizinische Wochenschrift (1946) 2006;131(27):1515-20.
2006: D V Schmitt; E Leitner; T Welte; Hartmut Lode
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
Infection 2006;34(3):127-34.
2006: Helen Sambatakou; Bertrand Dupont; Hartmut Lode; David W Denning
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
The American journal of medicine 2006;119(6):527.e17-24.
2006: R Erbes; K Oettel; M Raffenberg; Harald Mauch; Malina Schmidt-Ioanas; Hartmut Lode
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care.
The European respiratory journal 2006;27(6):1223-8.
2006: Andrés de Roux; Santiago Ewig; E García; María Angeles Marcos; Josep Mensa; Hartmut Lode; Antoni Torres
Mixed community-acquired pneumonia in hospitalised patients.
The European respiratory journal 2006;27(4):795-800.
2006: Malina Schmidt-Ioanas; Hartmut Lode
Treatment of pneumonia in elderly patients.
Expert opinion on pharmacotherapy 2006;7(5):499-507.
2006: Malina Schmidt-Ioanas; Mathias Pletz; Andres De Roux; Hartmut Lode
Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines.
Respiratory medicine 2006;100(4):639-47.
2006: S R Ott; Hartmut Lode
[Diagnosis and therapy of aspiration pneumonia].
Deutsche medizinische Wochenschrift (1946) 2006;131(12):624-8.
2006: Malina Schmidt-Ioanas; M Bender; A Roth; Markus Allewelt; Andres De Roux; Hartmut Lode
[Serologic early diagnosis of pneumonia caused by Mycoplasma pneumoniae].
Deutsche medizinische Wochenschrift (1946) 2006;131(12):613-7.
2006: H Worth; Hartmut Lode
[The wide spectrum of modern pneumology].
Deutsche medizinische Wochenschrift (1946) 2006;131(12):605.
2006: Andres De Roux; A Marx; Olaf Burkhardt; B Schweiger; A Borkowski; A Banzhoff; Mathias Pletz; Hartmut Lode
Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients.
Vaccine 2006;24(10):1537-42.
2006: Hartmut Lode
[New S3 guideline for therapy of bacterial respiratory tract infections. Renaissance of tetracyclines].
MMW Fortschritte der Medizin 2006;148(1-2):48.
2006: Hartmut Lode; R Erbes; A Linnhoff
[Management of community-acquired pneumonia in the physician's office].
MMW Fortschritte der Medizin 2006;148(1-2):32-5.
2006: Hartmut Lode
[Uses in in ambulatory and stationary situations. Clinical indications for beta lactams].
Pharmazie in unserer Zeit 2006;35(5):428-31.
2005: Thomas Schneider; Christoph Loddenkemper; Martin Rudwaleit; Hartmut Lode; Martin Zeitz
[Fever of unknown origin in the 21st century. 2. Non-infectious diseases (autoimmune diseases)].
Deutsche medizinische Wochenschrift (1946) 2005;130(48):2774-8.
2005: Hartmut Lode; Malina Schmidt-Ioanas
Vasculitis and infection: effects of immunosuppressive therapy.
Clinical nephrology 2005;64(6):475-9.
2005: A de Roux; Hartmut Lode
Pneumococcal vaccination.
The European respiratory journal 2005;26(6):982-3.
2005: Thomas Schneider; Christoph Loddenkemper; Martin Rudwaleit; Hartmut Lode; Martin Zeitz
[Fever of unknown origin in the 21st century: infectious diseases].
Deutsche medizinische Wochenschrift (1946) 2005;130(47):2708-12.
2005: Malina Schmidt-Ioanas; Andres De Roux; Hartmut Lode
New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Current opinion in critical care 2005;11(5):481-6.
2005: Hartmut Lode
Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(10):778-87.
2005: Hartmut Lode
[Infectious diseases during change].
Deutsche medizinische Wochenschrift (1946) 2005;130(37):2084-88.
2005: D Christensen; C Feldman; P Rossi; Thomas J Marrie; F Blasi; C Luna; P Fernandez; J Porras; J Martinez; K Weiss; G Levy; Hartmut Lode; P Gross; T File; J Ramirez
HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(4):554-6.
2005: Mathias Pletz; Hartmut Lode
Apoptosis of circulating neutrophils in COPD patients.
Chest 2005;127(4):1464; author reply 1464-5.
2005: Markus Rose; Hartmut Lode; Andres De Roux; Stefan Zielen
[Pneumococcal vaccination in obstructive lung diseases -- what can we expect?].
Deutsche medizinische Wochenschrift (1946) 2005;130(9):461-5.
2005: M Allewelt; Hartmut Lode
[Diagnosis of haemoptoe/haemoptysis].
Deutsche medizinische Wochenschrift (1946) 2005;130(9):450-2.
2005: C Witt; Hartmut Lode
[Pneumology -- epidemiological changes and structural consequences].
Deutsche medizinische Wochenschrift (1946) 2005;130(9):439.
2005: David A Groneberg; Susan M Poutanen; Donald E Low; Hartmut Lode; Tobias Welte; Peter Zabel
Treatment and vaccines for severe acute respiratory syndrome.
The Lancet infectious diseases 2005;5(3):147-55.
2005: Mathias Pletz; Lesley McGee; Olaf Burkhardt; Hartmut Lode; keith klugman
Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(1):58-60.
2004: C K Naber; A Bauhofer; M Block; M Buerke; R Erbel; W Graninger; M Herrmann; D Horstkotte; P Kern; Hartmut Lode; U Mehlhorn; J Meyer; A Mügge; J Niebel; G Peters; P M Shah; K Werdan
[S2 guideline for infectious endocarditis].
MMW Fortschritte der Medizin 2004;146(Suppl 3-4):123-35.
2004: Andres De Roux; N Schmidt; Markus Rose; Stefan Zielen; Mathias Pletz; Hartmut Lode
Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids.
Respiratory medicine 2004;98(12):1187-94.
2004: Hartmut Lode; J Eller; A Linnhoff; M Ioanas
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
The European respiratory journal 2004;24(6):947-53.
2004: Mathias Pletz; Mareike Rau; Jürgen Bulitta; Andres De Roux; Olaf Burkhardt; Guido Kruse; Michael Kurowski; Carl Erik Nord; Hartmut Lode
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.
Antimicrobial agents and chemotherapy 2004;48(10):3765-72.
2004: Peter Wutzler; K-D Kossow; Hartmut Lode; B R Ruf; H Scholz; G E Vogel
Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(2):84-91.
2004: M Voss; M Allewelt; Hartmut Lode
[Chronic eosinophilic pneumonia].
Deutsche medizinische Wochenschrift (1946) 2004;129(36):1858-60.
2004: Thomas M File; Hartmut Lode; H Kurz; R Kozak; H Xie; Elchonon Berkowitz
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
Antimicrobial agents and chemotherapy 2004;48(9):3323-31.
2004: T Schneider; T Ulrichs; C Loddenkemper; Hartmut Lode; Martin Zeitz; Hans Scherübl
[Intestinal tuberculosis: a clinical and diagnostic challenge].
Deutsche medizinische Wochenschrift (1946) 2004;129(33):1747-52.
2004: Hartmut Lode; Pál Magyar; J F Muir; U Loos; K Kleutgens
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(6):512-20.
2004: Thomas M File; Javier Garau; Francesco Blasi; Christian Chidiac; keith klugman; Hartmut Lode; John R Lonks; Lionel A Mandell; Julio Ramirez; Victor Yu
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Chest 2004;125(5):1888-901.
2004: Hartmut Lode; T Aronkyto; A G Chuchalin; M Jaaskevi; I Kahnovskii; K Kleutgens
A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(5):403-8.
2004: Mathias Pletz; M Ioanas; Andres De Roux; Olaf Burkhardt; Hartmut Lode
Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD.
The European respiratory journal 2004;23(4):532-7.
2004: Andrés de Roux; María Angeles Marcos; Elisa Garcia; Josep Mensa; Santiago Ewig; Hartmut Lode; Antoni Torres
Viral community-acquired pneumonia in nonimmunocompromised adults.
Chest 2004;125(4):1343-51.
2004: Mathias Pletz; Andres De Roux; Andreas Roth; Karl-Heinz Neumann; Harald Mauch; Hartmut Lode
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.
Antimicrobial agents and chemotherapy 2004;48(3):780-2.
2004: Malina Ioanas; Hartmut Lode
Linezolid in VAP by MRSA: a better choice?
Intensive care medicine 2004;30(3):343-6.
2004: Markus Allewelt; P Schüler; Pal Bölcskei; Harald Mauch; Hartmut Lode
Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(2):163-70.
2004: Marcus Zervos; Lionel A Mandell; Peter S Vrooman; Charles Andrews; Andrew McIvor; Ramzan H Abdulla; Pascal J de Caprariis; Charles A Knirsch; Guy W Amsden; Michael S Niederman; Hartmut Lode
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
Treatments in respiratory medicine 2004;3(5):329-36.
2003: Andrés de Roux; Hartmut Lode
Recent developments in antibiotic treatment.
Infectious disease clinics of North America 2003;17(4):739-51.
2003: Hartmut Lode; C Grossman; Shurjeel Choudhri; Daniel C Haverstock; J McGivern; Z Herman-Gnjidic; D Church
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia.
Respiratory medicine 2003;97(10):1134-42.
2003: A Kuhnke; Hartmut Lode
[Problems of pharmacotherapy of infections in the aged].
Der Internist 2003;44(8):986-94.
2003: Annette Lubasch; SU Ziege; B Brodersen; Klaus Borner; Peter Koeppe; Hartmut Lode
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(7):670-7.
2003: Olaf Burkhardt; Hans-Joachim Merker; Mehdi Shakibaei; Hartmut Lode
Electron microscopic findings in BAL of a fire-eater after petroleum aspiration.
Chest 2003;124(1):398-400.
2003: Mathias Pletz; P Petzold; A Allen; Olaf Burkhardt; Hartmut Lode
Effect of calcium carbonate on bioavailability of orally administered gemifloxacin.
Antimicrobial agents and chemotherapy 2003;47(7):2158-60.
2003: A Polzin; Mathias Pletz; R Erbes; M Raffenberg; Harald Mauch; S Wagner; Gisela Arndt; Hartmut Lode
Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.
The European respiratory journal 2003;21(6):939-43.
2003: M Solèr; Hartmut Lode; R Baldwin; J H A Levine; A J M Schreurs; Jan A van Noord; F P V Maesen; M Zehrer
Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(3):144-50.
2003: Annette Lubasch; Stefan Lück; Hartmut Lode; Harald Mauch; Joachim Lorenz; Pal Bölcskei; Tobias Welte
Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of severe chronic bronchitis.
The Journal of antimicrobial chemotherapy 2003;51(3):659-64.
2003: Mathias Pletz; V Preechachatchaval; Jürgen Bulitta; Markus Allewelt; Olaf Burkhardt; Hartmut Lode
ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate.
Antimicrobial agents and chemotherapy 2003;47(3):1129-31.
2003: Olaf Burkhardt; Markus Allewelt; Mathias Pletz; Tobias Welte; Hartmut Lode
Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary infection.
Scandinavian journal of infectious diseases 2003;35(8):516-8.
2003: Ralf Stahlmann; Hartmut Lode
Fluoroquinolones in the elderly: safety considerations.
Drugs & aging 2003;20(4):289-302.
2002: Hartmut Lode; Thomas M File; Lionel Mandell; Peter Ball; Rienk Pypstra; Michael Thomas
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
Clinical therapeutics 2002;24(11):1915-36.
2002: Olaf Burkhardt; Klaus Borner; Nicolas von der Höh; Peter Köppe; Mathias Pletz; Carl Erik Nord; Hartmut Lode
Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers.
The Journal of antimicrobial chemotherapy 2002;50(5):707-12.
2002: Dagmar Mainz; Klaus Borner; Peter Koeppe; Jochen Kotwas; Hartmut Lode
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.
The Journal of antimicrobial chemotherapy 2002;50(5):699-706.
2002: Hartmut Lode; Markus Allewelt
Role of newer fluoroquinolones in lower respiratory tract infections.
The Journal of antimicrobial chemotherapy 2002;50(1):151-4.
2002: Friedrich Vogel; Horst Scholz; B al-Nawas; W Elies; M Kresken; Hartmut Lode; O Müller; K G Naber; E Petersen; P Shah; Fritz Sörgel; W Stille; C Tauchnitz; M Trautmann; U Ullmann; H Wacha; B Wiedemann
[Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy].
Medizinische Monatsschrift für Pharmazeuten 2002;25(6):193-204.
2002: Hartmut Lode; Markus Allewelt
Role of newer fluoroquinolones in lower respiratory tract infections.
The Journal of antimicrobial chemotherapy 2002;49(5):709-12.
2002: H Grysczyk; Andres De Roux; A Grassot; Harald Mauch; Hartmut Lode
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
Deutsche medizinische Wochenschrift (1946) 2002;127(10):492-6.
2002: Hartmut Lode
Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
International journal of clinical practice. Supplement 2002;(125):10-17; discussion 37-9.
2002: David W Denning; Patricia Ribaud; Noël Milpied; Denis Caillot; Raoul Herbrecht; Eckhard Thiel; Andrea Haas; Markus Ruhnke; Hartmut Lode
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(5):563-71.
2002: Hartmut Lode; J Garau
Improving care for patients with respiratory tract infections.
Journal of chemotherapy (Florence, Italy) 2002;14 Suppl 2():22-8.
2002: Olaf Burkhardt; Klaus Borner; Heino Stass; Gabriele Beyer; Markus Allewelt; Carl Erik Nord; Hartmut Lode
Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces.
Scandinavian journal of infectious diseases 2002;34(12):898-903.
2001: M Allewelt; Hartmut Lode
[Diagnosis and therapy of abscess forming pneumonia].
Therapeutische Umschau. Revue thérapeutique 2001;58(10):599-603.
2001: Klaus Borner; E Borner; Hartmut Lode
Determination of linezolid in human serum and urine by high-performance liquid chromatography.
International journal of antimicrobial agents 2001;18(3):253-8.
2001: Hartmut Lode
Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections.
International journal of antimicrobial agents 2001;18(3):199-209.
2001: Petra Gastmeier; K D Beck; Hartmut Lode
[Respiratory filters and pneumonia: many unresolved questions].
Deutsche medizinische Wochenschrift (1946) 2001;126(30):835-9.
2001: M Raffenberg; T Szymanski; Annette Lubasch; R Erbes; S Wagner; K Weist; U Mansmann; Hartmut Lode
[Infections caused by Stenotrophomonas maltophilia (SMA) in intensive care patients--a prospective case-control study].
Deutsche medizinische Wochenschrift (1946) 2001;126(18):514-8.
2001: B R Ruf; Hartmut Lode
[Status of infectiology in Germany].
Deutsche medizinische Wochenschrift (1946) 2001;126(18):513.
2001: Hartmut Lode; R Erbes
[Idiopathic pulmonary fibrosis. III. Case report].
Deutsche medizinische Wochenschrift (1946) 2001;126(14):401.
2001: Hartmut Lode; R Erbes; M Raffenberg
[Idiopathic pulmonary fibrosis. II. Treatment].
Deutsche medizinische Wochenschrift (1946) 2001;126(14):399-401.
2001: R Erbes; M Raffenberg; Hartmut Lode
[Idiopathic pulmonary fibrosis. I. Diagnosis].
Deutsche medizinische Wochenschrift (1946) 2001;126(14):395-8.
2001: Annette Lubasch; R Erbes; Harald Mauch; Hartmut Lode
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy.
The European respiratory journal 2001;17(4):641-6.
2001: Hartmut Lode; N Von der Höh; SU Ziege; Klaus Borner; Carl Erik Nord
Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora.
Scandinavian journal of infectious diseases 2001;33(12):899-903.
2001: Hartmut Lode
Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpoint.
Chemotherapy 2001;47 Suppl 3():24-31; discussion 44-8.
2001: H J Woske; T Röding; I Schulz; Hartmut Lode
Ventilator-associated pneumonia in a surgical intensive care unit: epidemiology, etiology and comparison of three bronchoscopic methods for microbiological specimen sampling.
Critical care (London, England) 2001;5(3):167-73.
2001: Hartmut Lode; R Erbes; HF Geerdes-Fenge; M Raffenberg; Harald Mauch
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis].
Der Anaesthesist 2001;50(1):46-51.
2000: HF Geerdes-Fenge; A Wiedersich; S Wagner; K H Lehr; Peter Koeppe; Hartmut Lode
Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species.
Antimicrobial agents and chemotherapy 2000;44(12):3478-80.
2000: T Glück; S Opal; J Alattar-Mantis; T Weitzel; Hartmut Lode; J Schölmerich
Differences between American and German medical students and physicians in knowledge of infectious diseases.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(11):868-70.
2000: Hartmut Lode; R Erbes; HF Geerdes-Fenge; M Raffenberg; Harald Mauch
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis].
Der Internist 2000;41(11):1170, 1173-6, 1178-9.
2000: Annette Lubasch; I Keller; Klaus Borner; Peter Koeppe; Hartmut Lode
Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers.
Antimicrobial agents and chemotherapy 2000;44(10):2600-3.
2000: SU Ziege; HF Geerdes-Fenge; M Rau; Ulrike Buchwald; Hartmut Lode
In vitro effects of interleukin-10, prednisolone, and GM-CSF on the non-specific immune function of human polymorphonuclear leucocytes and monocytes.
European journal of medical research 2000;5(9):369-74.
2000: T File; B Schlemmer; J Garau; Hartmut Lode; S Lynch; C Young
Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
Journal of chemotherapy (Florence, Italy) 2000;12(4):314-25.
2000: Gabriele Beyer; M Hiemer-Bau; SU Ziege; C Edlund; Hartmut Lode; Carl Erik Nord
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(7):548-50.
2000: Thomas Glück; HF Geerdes-Fenge; R H Straub; M Raffenberg; B Lang; Hartmut Lode; Jurgen Schölmerich
Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy.
Infection 2000;28(4):227-30.
2000: Hardy-Thorsten Panknin; Hartmut Lode; M Kresken
[Clinical significance of infections in geriatric patients in long-term nursing care facilities].
Krankenpflege Journal 2000;38(5):170-6.
2000: A Lubasch; Hartmut Lode
[The role of antibiotic therapy in infectious enteritis].
Der Internist 2000;41(5):494-7.
2000: Hartmut Lode; Annette Lubasch; M Raffenberg; Harald Mauch
Clinical results in the treatment of respiratory infections with moxifloxacin.
Drugs of today (Barcelona, Spain : 1998) 2000;36(4):245-53.
2000: George L Drusano; Hartmut Lode; J R Edwards
Meropenem: clinical response in relation to in vitro susceptibility.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(4):185-94.
2000: Hartmut Lode
[Therapy recommendations for sarcoidosis].
Deutsche medizinische Wochenschrift (1946) 2000;125(9):252.
2000: Hartmut Lode
[Theme issue pneumology].
Deutsche medizinische Wochenschrift (1946) 2000;125(8):205.
2000: A Lubasch; Hartmut Lode
[Antibiotic therapy in cholecystitis, cholangitis and pancreatitis].
Der Internist 2000;41(2 Pt 1):168-74.
2000: Hartmut Lode; M Raffenberg; HF Geerdes-Fenge; Harald Mauch
Monotherapy of nosocomial pneumonia.
Seminars in respiratory and critical care medicine 2000;21(1):9-17.
2000: Hartmut Lode; J Eller; M Raffenberg; Harald Mauch
Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6 Suppl 3():87-9.
2000: C Edlund; Gabriele Beyer; M Hiemer-Bau; SU Ziege; Hartmut Lode; Carl Erik Nord
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora.
Scandinavian journal of infectious diseases 2000;32(1):81-5.
1999: Hartmut Lode
[Infectology. Globalized resistant pathogens and new vaccines].
Deutsche medizinische Wochenschrift (1946) 1999;124(51-52):1553-5.
1999: Hartmut Lode
[Amoxicillin/clavulanic acid (875/125 mg). New pharmacodynamic aspects].
Deutsche medizinische Wochenschrift (1946) 1999;124(48):1459-61.
1999: R Stahlmann; Hartmut Lode
[Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].
MMW Fortschritte der Medizin 1999;141(47):35-6.
1999: Petra Gastmeier; Hartmut Lode; Henning Rüden
[What is the evidence in the prevention ventilator-associated pneumonia? Evaluation of several controversial prevention measures in connection with ventilation and suction systems].
Deutsche medizinische Wochenschrift (1946) 1999;124(42):1241-4.
1999: Hartmut Lode
Potential interactions of the extended-spectrum fluoroquinolones with the CNS.
Drug safety : an international journal of medical toxicology and drug experience 1999;21(2):123-35.
1999: Klaus Borner; H Hartwig; Hartmut Lode
Determination of trovafloxacin in human body fluids by high-performance liquid chromatography.
Journal of chromatography. A 1999;846(1-2):175-80.
1999: R Stahlmann; J Eller; Hartmut Lode
[New understanding in the study of infectious diseases. Report of the 25th Ludwig Heilmeyer Symposium of the Society for the Advancement of Internal Medicine].
Deutsche medizinische Wochenschrift (1946) 1999;124(21):670-3.
1999: S Lober; SU Ziege; M Rau; G Schreiber; A Mignot; Peter Koeppe; Hartmut Lode
Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium.
Antimicrobial agents and chemotherapy 1999;43(5):1067-71.
1999: K Riecke; J Eller; C Gericke; Hartmut Lode
[Inpatient treatment costs of exacerbated chronic obstructive lung disease].
Pneumologie (Stuttgart, Germany) 1999;53(4):199-206.
1999: M Raffenberg; HF Geerdes-Fenge; H Müller-Pawlowski; M Petri; T Schaberg; R Loddenkemper; Hartmut Lode
[Invasive and non-invasive home ventilation--changes between 1982 and 1996].
Medizinische Klinik (Munich, Germany : 1983) 1999;94(1 Spec No):18-21.
1999: Ulrike Buchwald; HF Geerdes-Fenge; J Vöckler; SU Ziege; Hartmut Lode
Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone.
European journal of medical research 1999;4(3):85-94.
1999: J S Bradley; J Garau; Hartmut Lode; K V Rolston; S E Wilson; J P Quinn
Carbapenems in clinical practice: a guide to their use in serious infection.
International journal of antimicrobial agents 1999;11(2):93-100.
1999: Ralf Stahlmann; Hartmut Lode
Toxicity of quinolones.
Drugs 1999;58 Suppl 2():37-42.
1999: Hartmut Lode; F Vogel; W Elies
Grepafloxacin: a review of its safety profile based on clinical trials and postmarketing surveillance.
Clinical therapeutics 1999;21(1):61-74; discussion 1-2.
1999: Hartmut Lode
[Inhalational anticholinergic versus inhaled beta-mimetic drugs in COPD].
Der Internist 1999;40(1):114.
1998: R Stahlmann; Hartmut Lode
Safety of quinolones.
Lancet 1998;352(9136):1313.
1998: Hartmut Lode; Klaus Borner; Peter Koeppe
Pharmacodynamics of fluoroquinolones.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(1):33-9.
1998: J Eller; A Ede; Tom Schaberg; Michael S Niederman; Harald Mauch; Hartmut Lode
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.
Chest 1998;113(6):1542-8.
1998: Heinrich Worth; D Adam; Werner Handrick; Wolfgang Leupold; Hartmut Lode; U Loos; R Marre; Harald Mauch; Tom Schaberg; P Shah; V Sill; Ralf Wettengel
[Prevention and therapy of bronchial infections. Recommendations of the German Respiratory League of the German Society of Pneumology].
Pneumologie (Stuttgart, Germany) 1998;52(4):232-7.
1998: Hartmut Lode; T Schaberg; M Raffenberg; Harald Mauch
Nosocomial pneumonia in the critical care unit.
Critical care clinics 1998;14(1):119-33.
1997: Heinrich Worth; D Adam; Werner Handrick; Wolfgang Leupold; Hartmut Lode; U Loos; R Marre; Harald Mauch; Tom Schaberg; P Shah; V Sill; Ralf Wettengel
[Prophylaxis and therapy of bronchial infections. Recommendations of the German Airway League of the German Pulmonology Association].
Medizinische Klinik (Munich, Germany : 1983) 1997;92(12):699-704.
1997: M Allewelt; D Steinhoff; M Rahlwes; H Vogel-Hartmann; G Höffken; T Schaberg; Hartmut Lode
[Changes in the spectrum of the causative agents of community-acquired pneumonias (1982-1992)].
Deutsche medizinische Wochenschrift (1946) 1997;122(34-35):1027-32.
1997: J A Zix; HF Geerdes-Fenge; M Rau; J Vöckler; Klaus Borner; Peter Koeppe; Hartmut Lode
Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.
Antimicrobial agents and chemotherapy 1997;41(8):1668-72.
1997: K Riecke; S Wagner; J Eller; Hartmut Lode; Tom Schaberg
[Pulmonary melioidosis in a German Southeast Asia tourist].
Pneumologie (Stuttgart, Germany) 1997;51(5):499-502.
1997: W R Wilson; Emilio Bouza; Hartmut Lode; Y Mouton
The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.
Journal of chemotherapy (Florence, Italy) 1997;9 Suppl 2():5-18.
1997: P Schüler; K Zemper; Klaus Borner; Peter Koeppe; T Schaberg; Hartmut Lode
Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
The European respiratory journal 1997;10(5):1130-6.
1997: M G Petri; J König; Heinzpeter Moecke; HJ Gramm; H Barkow; P Kujath; R Dennhart; H Schäfer; N Meyer; P Kalmar; P Thülig; J Müller; Hartmut Lode
Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.
Intensive care medicine 1997;23(3):317-25.
1997: Hartmut Lode; T Schaberg; M Raffenberg
[The therapy of nosocomial pneumonia].
Deutsche medizinische Wochenschrift (1946) 1997;122(4):93-6.
1997: Tom Schaberg; Hartmut Lode
[The diagnosis of nosocomial pneumonia].
Deutsche medizinische Wochenschrift (1946) 1997;122(3):61-4.
1997: HF Geerdes-Fenge; B Goetschi; M Rau; Klaus Borner; Peter Koeppe; K Wettich; Hartmut Lode
Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva.
European journal of clinical pharmacology 1997;53(2):127-33.
1997: Tom Schaberg; C Theilacker; O T Nitschke; Hartmut Lode
Lymphocyte subsets in peripheral blood and smoking habits.
Lung 1997;175(6):387-94.
1996: R Erbes; A Wagner; T Schaberg; Hartmut Lode; H Mauch; Wolfgang Witte
[MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with pulmonary diseases].
Pneumologie (Stuttgart, Germany) 1996;50(10):706-11.
1996: Tom Schaberg; K Rebhan; Hartmut Lode
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis.
The European respiratory journal 1996;9(10):2026-30.
1996: Hartmut Lode; T Schaberg
[Pneumonia].
Pneumologie (Stuttgart, Germany) 1996;50 Suppl 2():592-4.
1996: Hartmut Lode; D Steinhoff; T Schaberg; Harald Mauch
[New pneumonia pathogens, especially Chlamydia pneumoniae and Hantaviruses].
Der Internist 1996;37(9):882-9.
1996: H Müller-Pawlowski; M Raffenberg; Tom Schaberg; M Petri; Hartmut Lode
[Intermittent nasal positive pressure ventilation with a ventilator in accordance with the Medical Device Regulation III (MedGV III). Clinical experiences with the BREAS PV 201 in 19 patients].
Pneumologie (Stuttgart, Germany) 1996;50(8):518-22.
1996: Hartmut Lode
Clinical indications for beta-lactamase inhibitors in comparison to other antibiotics.
International journal of antimicrobial agents 1996;7 Suppl 1():S3-7.
1996: Hartmut Lode; K Borner; P Koeppe; Tom Schaberg
Azithromycin--review of key chemical, pharmacokinetic and microbiological features.
The Journal of antimicrobial chemotherapy 1996;37 Suppl C():1-8.
1996: D Steinhoff; Hartmut Lode; G Ruckdeschel; B Heidrich; A Rolfs; F J Fehrenbach; Harald Mauch; G Höffken; J Wagner
Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(6):958-64.
1996: D Adam; H Grimm; Hartmut Lode
Re: A. Bauernfeind et al.: Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens (Infection 23 [1995] 316-321)
Infection 1996;24(3):270-1.
1996: M Aubier; Hartmut Lode; G Gialdroni-Grassi; G Huchon; J Hosie; N Legakis; C Regamey; S Segev; R Vester; W J Wijnands; N Tolstuchow
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
The Journal of antimicrobial chemotherapy 1996;37 Suppl A():73-82.
1996: Hartmut Lode
Preface.
International journal of antimicrobial agents 1996;6 Suppl():v-vi.
1996: Ludwig G. Strauss; D Kabelitz; B Kremer; Hartmut Lode; T Meinertz; T Sauerbruch; W Sterry
[Use of positron-emission tomography in oncology].
Deutsche medizinische Wochenschrift (1946) 1996;121(7):207-9.
1996: T Schülin; Tom Schaberg; Hartmut Lode
[Therapy of lung abscesses].
Deutsche medizinische Wochenschrift (1946) 1996;121(5):137-8.
1996: T Schülin; Tom Schaberg; Hartmut Lode
[Diagnosis of lung abscesses].
Deutsche medizinische Wochenschrift (1946) 1996;121(5):135-6.
1996: Hartmut Lode
[Sputum gram staining in pneumonia].
Deutsche medizinische Wochenschrift (1946) 1996;121(4):114-5.
1996: Tom Schaberg; M Rau; R Oerter; U Liebers; W Rahn; D Kaiser; C Witt; Hartmut Lode
Expression of adhesion molecules in peripheral pulmonary vessels from smokers and nonsmokers.
Lung 1996;174(2):71-81.
1996: M Dreetz; J Hamacher; J Eller; K Borner; P Koeppe; Tom Schaberg; Hartmut Lode
Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.
Antimicrobial agents and chemotherapy 1996;40(1):105-9.
1996: Tom Schaberg; G Gloger; B Reichert; Harald Mauch; Hartmut Lode
[Resistant lung tuberculosis in Berlin 1987-1993].
Pneumologie (Stuttgart, Germany) 1996;50(1):21-7.
1995: Hartmut Lode; J Garau; C Grassi; J Hosie; G Huchon; N Legakis; S Segev; G Wijnands
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin.
The European respiratory journal 1995;8(12):1999-2007.
1995: A Rolfs; Joachim Beige; Ulrich Finckh; B Köhler; Tom Schaberg; J Lokies; Hartmut Lode
Amplification of Mycobacterium tuberculosis from peripheral blood.
Journal of clinical microbiology 1995;33(12):3312-4.
1995: Tom Schaberg; B Reichert; T Schülin; Hartmut Lode; Harald Mauch
Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media.
The European respiratory journal 1995;8(10):1688-93.
1995: J Hamacher; F Vogel; J Lichey; F V Kohl; K Diwok; H Wendel; Hartmut Lode
Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group.
The Journal of antimicrobial chemotherapy 1995;36 Suppl A():121-33.
1995: Holger Hof; Hartmut Lode
[A single dosage of aminoglycosides?].
Deutsche medizinische Wochenschrift (1946) 1995;120(25-26):935-7.
1995: T Schaberg; N Schönfeld; Robert Loddenkemper; Hartmut Lode
[Therapy of sarcoidosis].
Deutsche medizinische Wochenschrift (1946) 1995;120(20):725-7.
1995: N Schönfeld; T Schaberg; Hartmut Lode; Robert Loddenkemper
[Diagnosis of sarcoidosis].
Deutsche medizinische Wochenschrift (1946) 1995;120(19):687-9.
1995: T Schaberg; U Klein; M Rau; J Eller; Hartmut Lode
Subpopulations of alveolar macrophages in smokers and nonsmokers: relation to the expression of CD11/CD18 molecules and superoxide anion production.
American journal of respiratory and critical care medicine 1995;151(5):1551-8.
1995: H Stuht; Hartmut Lode; P Koeppe; K L Rost; T Schaberg
Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
Antimicrobial agents and chemotherapy 1995;39(5):1045-9.
1995: Ethan Rubinstein; Hartmut Lode; C Grassi
Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(5):1217-28.
1995: Hartmut Lode
Cefotaxime for the 1990s.
Diagnostic microbiology and infectious disease 1995;22(1-2):1-3.
1995: Hartmut Lode; T Schaberg; R Stahlmann
Selective decontamination of the digestive tract: indications and problems.
Infection 1995;23(3):129-32.
1995: H J Gramm; L Hannemann; Konrad Reinhart; Hartmut Lode
[Sepsis: a conception in change. Possibilities and limitations of diagnosis based on clinical criteria].
Deutsche medizinische Wochenschrift (1946) 1995;120(14):498-502.
1995: R C Bittner; N Schnoy; N Schönfeld; A Grassot; Robert Loddenkemper; Hartmut Lode; D Kaiser; D Krumhaar; Roland Felix
[High-resolution magnetic resonance tomography (HR-MRT) of the pleura and thoracic wall: normal findings and pathological changes].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1995;162(4):296-303.
1995: H Müller-Pawlowski; A von Moers; M Raffenberg; M Petri; S Saalfeld; Hartmut Lode
[BiPAP therapy of respiratory disorders in patients with congenital neuromuscular diseases].
Medizinische Klinik (Munich, Germany : 1983) 1995;90(1 Suppl 1):35-8.
1995: Tom Schaberg; G Gloger; B Reichert; Harald Mauch; Hartmut Lode
Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993.
The European respiratory journal 1995;8(2):278-84.
1995: T Schaberg; Hartmut Lode
[Diagnosis of pulmonary infections].
Der Internist 1995;36(2):146-50.
1995: Hartmut Lode; Tom Schaberg; M Raffenberg; Harald Mauch
Lower respiratory tract infections in the intensive care unit: consequences of antibiotic resistance for choice of antibiotic.
Microbial drug resistance (Larchmont, N.Y.) 1995;1(2):163-7.
1995: Hartmut Lode; J Hamacher; J Eller; Tom Schaberg
Changing role of carbapenems in the treatment of lower respiratory tract infections.
Scandinavian journal of infectious diseases. Supplementum 1995;96():17-23.
1995: Joachim Beige; J Lokies; Tom Schaberg; Ulrich Finckh; M Fischer; Harald Mauch; Hartmut Lode; B Köhler; A Rolfs
Clinical evaluation of a Mycobacterium tuberculosis PCR assay.
Journal of clinical microbiology 1995;33(1):90-5.
1994: D Ziegler; Hartmut Lode; M Raffenberg; Tom Schaberg; Harald Mauch; A Grassot
[Incompatibility of tuberculosis therapy in a patient with AIDS].
Deutsche medizinische Wochenschrift (1946) 1994;119(50):1728-33.
1994: T Schaberg; Hartmut Lode
[Immunization in pneumology].
Pneumologie (Stuttgart, Germany) 1994;48(8):505-10.
1994: Tom Schaberg; K Orzechowski; C Oesterling; Hartmut Lode; Detlef Schuppan
Simultaneous measurement of collagen type-VI-related antigen and procollagen type-III-N-propeptide levels in bronchoalveolar lavage.
The European respiratory journal 1994;7(7):1221-6.
1994: J Eller; J R Lapa e Silva; L W Poulter; Hartmut Lode; P J Cole
Cells and cytokines in chronic bronchial infection.
Annals of the New York Academy of Sciences 1994;725():331-45.
1994: M Ritz; Hartmut Lode; M Fassbender; Klaus Borner; Peter Koeppe; C E Nord
Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.
Antimicrobial agents and chemotherapy 1994;38(3):455-9.
1994: M Raffenberg; Tom Schaberg; H Müller-Pawlowski; Hartmut Lode
[Indications for and use of home artificial respiration].
Deutsche medizinische Wochenschrift (1946) 1994;119(6):187-91.
1994: Hartmut Lode; M Fassbender; T Schaberg; Klaus Borner; Peter Koeppe
Comparative pharmacokinetics of the new oral cephalosporins.
Drugs 1994;47 Suppl 3():10-9; discussion 19-20.
1993: Hartmut Lode
[The treatment of multiply resistant pulmonary tuberculosis].
Deutsche medizinische Wochenschrift (1946) 1993;118(46):1706-7.
1993: T Schaberg; Hartmut Lode
[Influenza infection and antibiotic therapy].
Deutsche medizinische Wochenschrift (1946) 1993;118(45):1663.
1993: J M Eller; T Schaberg; Hartmut Lode
[The therapy of bronchiectasis].
Deutsche medizinische Wochenschrift (1946) 1993;118(44):1608-10.
1993: J M Eller; T Schaberg; Hartmut Lode
[The clinical picture and diagnosis of bronchiectasis].
Deutsche medizinische Wochenschrift (1946) 1993;118(44):1605-7.
1993: R Dennhardt; H J Gramm; C Wiegand-Löhnert; Hartmut Lode
[Antimycotic therapy on intensive care units: contra].
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 1993;28(7):453-6.
1993: T Schaberg; H Mauch; Hartmut Lode
[The clinical significance of penicillin-resistant pneumococci].
Deutsche medizinische Wochenschrift (1946) 1993;118(41):1491-7.
1993: T Schaberg; Hartmut Lode
[Influenza infection and antibiotic therapy].
Deutsche medizinische Wochenschrift (1946) 1993;118(40):1464.
1993: J Günther; Hartmut Lode; M Raffenberg; T Schaberg
Development of pleural and pericardial effusions during itraconazole therapy of pulmonary aspergillosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(9):723-4.
1993: W Paulfeuerborn; H J Müller; K Borner; P Koeppe; Hartmut Lode
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
Antimicrobial agents and chemotherapy 1993;37(9):1835-41.
1993: Hartmut Lode; Tom Schaberg; M Raffenberg; Harald Mauch
Diagnostic problems in lower respiratory tract infections.
The Journal of antimicrobial chemotherapy 1993;32 Suppl A():29-37.
1993: T Schaberg; M Rau; H Stephan; Hartmut Lode
Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells.
The American review of respiratory disease 1993;147(6 Pt 1):1507-13.
1993: Klaus Borner; E Borner; Hartmut Lode
Determination of a new cephalosporin, SCE-2787, in serum and urine by high-performance liquid chromatography.
Journal of chromatography 1993;615(1):174-9.
1993: Thomas Schneider; Hans-Ulrich Jahn; D Steinhoff; H M Guschoreck; O Liesenfeld; H Mäter-Böhm; A L Wesirow; Hartmut Lode; W D Ludwig; T Dissmann
[A Q fever epidemic in Berlin. The epidemiological and clinical aspects].
Deutsche medizinische Wochenschrift (1946) 1993;118(19):689-95.
1993: M Fassbender; Hartmut Lode; T Schaberg; Klaus Borner; Peter Koeppe
Pharmacokinetics of new oral cephalosporins, including a new carbacephem.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(5):646-53.
1993: Hartmut Lode; T Schaberg
Rational approach to the diagnosis of Pneumocystis carinii pneumonia (PCP)
The European respiratory journal 1993;6(2):166-8.
1993: K M Deppermann; Hartmut Lode
Fluoroquinolones: interaction profile during enteral absorption.
Drugs 1993;45 Suppl 3():65-72.
1992: H F Geerdes; D Ziegler; Hartmut Lode; M Hund; A Loehr; W Fangmann; J Wagner
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(6):991-1002.
1992: T Schaberg; Hartmut Lode
[Therapy of pulmonary mycoses].
Deutsche medizinische Wochenschrift (1946) 1992;117(45):1725-9.
1992: T Schaberg; C Lauer; Hartmut Lode; J Fischer; H Haller
Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production.
The American review of respiratory disease 1992;146(5 Pt 1):1287-93.
1992: T Schaberg; H Mauch; Hartmut Lode
[The clinical picture and diagnosis of pulmonary mycoses].
Deutsche medizinische Wochenschrift (1946) 1992;117(44):1681-4.
1992: T Schaberg; Hartmut Lode
[Therapy of urogenital tuberculosis].
Deutsche medizinische Wochenschrift (1946) 1992;117(37):1418-9.
1992: Klaus Borner; E Borner; Hartmut Lode
Determination of sparfloxacin in serum and urine by high-performance liquid chromatography.
Journal of chromatography 1992;579(2):285-9.
1992: S Roller; Hartmut Lode; I Stelzer; K M Deppermann; M Boeckh; Peter Koeppe
Pharmacokinetics of loracarbef and interaction with acetylcysteine.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(9):851-5.
1992: K Bächer; M Schaeffer; Hartmut Lode; C E Nord; Klaus Borner; Peter Koeppe
Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers.
The Journal of antimicrobial chemotherapy 1992;30(3):365-75.
1992: T Schaberg; Hartmut Lode
[Ambulant atypical pneumonia: clinical diagnosis and therapy].
Immunität und Infektion 1992;20(4):136-7.
1992: Hartmut Lode; T Schaberg; G Höffken
[Chemotherapeutic prevention of infection in invasive interventions in high-risk internal medicine patients].
Der Internist 1992;33(6):418-24.
1992: M Boeckh; Hartmut Lode; G Höffken; S Daeschlein; Peter Koeppe
Pharmacokinetics of roxithromycin and influence of H2-blockers and antacids on gastrointestinal absorption.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(5):465-8.
1992: D Adam; R Ferlinz; R Frei; L Geisler; H Knothe; Hartmut Lode; P Shah
[Antibacterial therapy in infectious bronchial diseases. Recommendations of the German League for control of respiratory tract diseases].
Medizinische Monatsschrift für Pharmazeuten 1992;15(4):100-5.
1992: N Saathoff; Hartmut Lode; K Neider; K M Depperman; K Borner; P Koeppe
Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.
Antimicrobial agents and chemotherapy 1992;36(4):796-800.
1992: T Schaberg; H Haller; M Rau; D Kaiser; M Fassbender; Hartmut Lode
Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers.
The European respiratory journal 1992;5(4):387-93.
1992: Hartmut Lode; T Schaberg; H Lebahn
[Value of serum bactericidal test for the treatment of infection].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(2):94-5.
1992: T Schaberg; Christian Witt; Hartmut Lode
[Bronchoscopic diagnosis of pneumonia].
Zeitschrift für ärztliche Fortbildung 1992;86(1-2):57-62.
1992: Hartmut Lode; G Höffken; B Kemmerich; T Schaberg
Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU.
Intensive care medicine 1992;18 Suppl 1():S24-7.
1992: Hartmut Lode; C Müller; Klaus Borner; C E Nord; Peter Koeppe
Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.
Antimicrobial agents and chemotherapy 1992;36(1):144-9.
1992: Hartmut Lode; Tom Schaberg
Azithromycin in lower respiratory tract infections.
Scandinavian journal of infectious diseases. Supplementum 1992;83():26-33.
1991: T Schaberg; Hartmut Lode
[The antibiotic therapy of community-acquired pneumonias].
Deutsche medizinische Wochenschrift (1946) 1991;116(50):1917-20.
1991: T Schaberg; Hartmut Lode
[Clinical aspects and diagnosis of community-acquired pneumonia].
Deutsche medizinische Wochenschrift (1946) 1991;116(49):1877-80.
1991: F Vogel; Hartmut Lode
The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.
The Journal of antimicrobial chemotherapy 1991;28 Suppl C():81-6.
1991: Hermann Haller; T Schaberg; Carsten Lindschau; Hartmut Lode; Armin Distler
Endothelin increases [Ca2+]i, protein phosphorylation, and O2-. production in human alveolar macrophages.
The American journal of physiology 1991;261(6 Pt 1):L478-84.
1991: T Schaberg; J Eller; S Wernitz; U Küstner; Hartmut Lode
[Pulmonary parasitoses as differential diagnosis of lung tuberculosis].
Zeitschrift für ärztliche Fortbildung 1991;85(19):937-42.
1991: Hartmut Lode
The pharmacokinetics of azithromycin and their clinical significance.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(10):807-12.
1991: T Schaberg; W Rahn; P Racz; Hartmut Lode
Pulmonary schistosomiasis resembling acute pulmonary tuberculosis.
The European respiratory journal 1991;4(8):1023-6.
1991: J Lichey; I Reschofski; T Dissmann; M Priesnitz; M Hoffmann; Hartmut Lode
Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism.
Klinische Wochenschrift 1991;69(12):522-6.
1991: T Schaberg; Hermann Haller; Hartmut Lode
Evidence for a platelet-activating factor receptor on human alveolar macrophages.
Biochemical and biophysical research communications 1991;177(2):704-10.
1991: T Schaberg; Hartmut Lode
[Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1991;46(8):276-9.
1991: Hartmut Lode; T Schaberg; G Höffken; R Schröder
[Clinical aspects of endocarditis].
Immunität und Infektion 1991;19(2):42-4.
1991: Hartmut Lode
Respiratory tract infections: when is antibiotic therapy indicated?
Clinical therapeutics 1991;13(1):149-56; discussion 148.
1991: Hartmut Lode
[Use and risk of antibacterial chemotherapy from the medical point of view].
Infection 1991;19 Suppl 1():S72-3.
1990: M Boeckh; Hartmut Lode; K M Deppermann; S Grineisen; F Shokry; R Held; K Wernicke; Peter Koeppe; J Wagner; C Krasemann
Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.
Antimicrobial agents and chemotherapy 1990;34(12):2407-14.
1990: T Schaberg; Hartmut Lode
[Therapy of tuberculosis].
Deutsche medizinische Wochenschrift (1946) 1990;115(47):1799-802.
1990: T Schaberg; Hartmut Lode
[Diagnosis of tuberculosis].
Deutsche medizinische Wochenschrift (1946) 1990;115(47):1795-8.
1990: Hartmut Lode
[Current trends in the therapy of respiratory tract infections].
Medizinische Klinik (Munich, Germany : 1983) 1990;85(11):661-4.
1990: Hartmut Lode; G Höffken; M Boeckk; N Deppermann; Klaus Borner; Peter Koeppe
Quinolone pharmacokinetics and metabolism.
The Journal of antimicrobial chemotherapy 1990;26 Suppl B():41-9.
1990: Hartmut Lode; R Stahlmann
Evaluation of safety and tolerance in clinical trials with antimicrobial agents.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(7):530-3.
1990: A Saathoff; Hartmut Lode; B Hampel; K M Deppermann; Klaus Borner; Peter Koeppe
Pharmacokinetics of FCE 22891, a new oral penem.
Antimicrobial agents and chemotherapy 1990;34(6):1001-6.
1990: Hartmut Lode
[Infections of the airways--when are antibiotics indicated?].
Pneumologie (Stuttgart, Germany) 1990;44(5):763-6.
1990: G Höffken; C Elsing; M Ruhnke; M Franke; M Schrappe-Bächer; H J Stellbrink; R Weiss; H Noack; M Petri; Hartmut Lode
[Randomized comparative study of secondary prevention of Pneumocystis carinii pneumonia in patients with acquired immunologic deficiency syndrome].
Medizinische Klinik (Munich, Germany : 1983) 1990;85 Suppl 2():281-5.
1990: D Mainz; N Mülleneisen; G Höffken; B Kemmerich; J Wagner; Hartmut Lode
[Value of diagnostic procedures in fiberoptic bronchoscopy of pulmonary infections].
Pneumologie (Stuttgart, Germany) 1990;44 Suppl 1():471-2.
1990: Hartmut Lode; G Höffken; T Dissmann; H Schäfer
[Intensive care problems in AIDS patients].
Pneumologie (Stuttgart, Germany) 1990;44 Suppl 1():407-8.
1990: Hartmut Lode
Development of clinically important resistance to quinolones and other antibiotic groups.
The Journal of international medical research 1990;18 Suppl 4():27D-36D.
1990: Hartmut Lode; E Wiley; P Olschewski; H Sievers; M Wintermantel; R Baetz; K Lebahn; M Reinke; J Wagner; Klaus Borner
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Scandinavian journal of infectious diseases. Supplementum 1990;68():50-5.
1990: Hartmut Lode; M Boeckh; G Höffken; M Kühn; H Gaffal; Klaus Borner; Peter Koeppe
Comparative pharmacokinetics of glycopeptide antibiotics, and the influence of teicoplanin on granulocyte function.
Scandinavian journal of infectious diseases. Supplementum 1990;72():9-13.
1990: U F Schade; I Burmeister; R Engel; Hartmut Lode; I Kozka
The role of 13-hydroxylinoleic acid in the activation of macrophages by lipopolysaccharide.
Advances in experimental medicine and biology 1990;256():361-8.
1990: Hartmut Lode; G Höffken; M Boeckh; D Mainz
[Bronchitis and obstructive bronchitis].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1990;96():45-8.
1989: K M Deppermann; M Boeckh; S Grineisen; F Shokry; Klaus Borner; Peter Koeppe; C Krasemann; J Wagner; Hartmut Lode
Combination effects of ciprofloxacin, clindamycin, and metronidazole intravenously in volunteers.
The American journal of medicine 1989;87(5A):46S-48S.
1989: Hartmut Lode; G Hoffken; Klaus Borner; Peter Koeppe
Ciprofloxacin intravenous dose variance.
The American journal of medicine 1989;87(5A):40S-45S.
1989: M Boeckh; G Höffken; Hartmut Lode
[The spectrum of pulmonary manifestations of aspergillosis].
Deutsche medizinische Wochenschrift (1946) 1989;114(44):1706-9.
1989: K M Deppermann; Hartmut Lode; G Höffken; G Tschink; C Kalz; Peter Koeppe
Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid.
Antimicrobial agents and chemotherapy 1989;33(11):1901-7.
1989: B Kemmerich; M Rahlwes; H Vogel-Hartmann; K Bartmann; G Höffken; E Berntsson; G Ruckdeschel; J Wagner; Hartmut Lode
[Community-acquired pneumonia].
Deutsche medizinische Wochenschrift (1946) 1989;114(39):1471-7.
1989: Hartmut Lode; N Deppermann; U Schmidt
[Bioequivalence of an optimized doxycycline preparation].
Arzneimittel-Forschung 1989;39(9):1162-5.
1989: Hartmut Lode; R Schröder
[Possibilities for errors in endocarditis therapy].
Der Internist 1989;30(8):492-7.
1989: F Müller; M Hund; J Löhr; Hartmut Lode; J Wagner; W Fangmann
[Infection 1979 to 1986. Epidemiology, etiology, clinical aspects and prognosis in 691 patients].
Medizinische Klinik (Munich, Germany : 1983) 1989;84(7):323-8.
1989: Hartmut Lode
Pharmacokinetics and clinical results of parenterally administered new quinolones in humans.
Reviews of infectious diseases 1989;11 Suppl 5():S996-1004.
1989: Hartmut Lode; M Springsklee
[Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
Medizinische Klinik (Munich, Germany : 1983) 1989;84(5):236-41.
1989: D Sassella; G Cassinelli; R Corigli; P Dewland; V Hutt; Hartmut Lode; R C Ballard
Urinary recovery and tolerability of FCE 22101 following single intravenous administration under restricted and high fluid intake.
The Journal of antimicrobial chemotherapy 1989;23 Suppl C():197-203.
1989: Ulrich Kunzendorf; F Keller; Gerd Walz; H Haller; G Offermann; K Borner; Hartmut Lode
Multivariate analysis of aminoglycoside levels in hemodialysis patients.
Chemotherapy 1989;35(1):1-6.
1989: Hartmut Lode; G Höffken
Oral candidosis and its role in immunocompromised patients.
Mycoses 1989;32 Suppl 2():30-3.
1989: Hartmut Lode
[Frequent errors in antibiotic therapy].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1989;95():400-3.
1989: Hartmut Lode; B Hampel; G Bruckner; Peter Koeppe
The pharmacokinetics of sultamicillin.
APMIS. Supplementum 1989;5():17-22.
1989: Hartmut Lode; G Höffken; K Borner; Peter Koeppe
Unique aspects of quinolone pharmacokinetics.
Clinical pharmacokinetics 1989;16 Suppl 1():1-4.
1988: Hartmut Lode
[Quinolones].
Schweizerische medizinische Wochenschrift 1988;118(49):1823-30.
1988: Hartmut Lode; G Höffken; P Olschewski; B Sievers; A Kirch; Klaus Borner; Peter Koeppe
Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
The Journal of antimicrobial chemotherapy 1988;22 Suppl C():73-9.
1988: G Höffken; Hartmut Lode; T Dissmann; W D Ludwig; K F Hunsdiek; A Krämer; H Hampl; B Zorr; M Mielke; B Bratzke
[Pulmonary complications in acquired immunodeficiency syndrome. Results of a prospective study].
Deutsche medizinische Wochenschrift (1946) 1988;113(19):755-62.
1988: B Kemmerich; R Stahlmann; Hartmut Lode
[Fluoroquinolone. 2. Pharmacokinetics and clinical use].
Deutsche medizinische Wochenschrift (1946) 1988;113(17):693-5.
1988: R Stahlmann; B Kemmerich; Hartmut Lode
[Fluoroquinolones. 1. Their chemical structure, mechanism of action and antibacterial activity].
Deutsche medizinische Wochenschrift (1946) 1988;113(16):648-51.
1988: Hartmut Lode
Microbiological and clinical aspects of aspiration pneumonia.
The Journal of antimicrobial chemotherapy 1988;21 Suppl C():83-90.
1988: M Boeckh; Hartmut Lode; Klaus Borner; G Höffken; J Wagner; Peter Koeppe
Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers.
Antimicrobial agents and chemotherapy 1988;32(1):92-5.
1988: Hartmut Lode
Drug interactions with quinolones.
Reviews of infectious diseases 1988;10 Suppl 1():S132-6.
1988: B Hampel; Hartmut Lode; G Bruckner; Peter Koeppe
Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers.
Drugs 1988;35 Suppl 7():29-33.
1987: Hartmut Lode; R Wiley; G Höffken; J Wagner; Klaus Borner
Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
Antimicrobial agents and chemotherapy 1987;31(10):1491-6.
1987: Hartmut Lode; G Höffken; P Olschewski; B Sievers; A Kirch; Klaus Borner; Peter Koeppe
Pharmacokinetics of ofloxacin after parenteral and oral administration.
Antimicrobial agents and chemotherapy 1987;31(9):1338-42.
1987: F Keller; K Borner; A Schwarz; G Offermann; Hartmut Lode
Therapeutic aminoglycoside monitoring in renal failure patients.
Therapeutic drug monitoring 1987;9(2):148-53.
1987: Hartmut Lode; B Kemmerich; H Schäfer; R Grothe; R Hartmann; W Ehret; G Ruckdeschel
Significance of non-pneumophila Legionella species in adult community-acquired and nosocomial pneumonias.
Klinische Wochenschrift 1987;65(10):463-8.
1987: G Höffken; H Rühl; H Seibt; A Meeth; Hartmut Lode; H Nekarda; I Wagner; I Horbach; A Rodloff; K Janitschke
Increased awareness of aspergillosis in acute leukemia patients.
Haematology and blood transfusion 1987;30():535-7.
1987: B M Harnoss; A Hirner; H Dibbelt; R Häring; R Rodloff; Hartmut Lode
Perioperative antibiotic prophylaxis in bile-duct interventions: results of two prospective randomized studies.
Chemotherapy 1987;33(4):297-301.
1987: Hartmut Lode
Consideration of the uses and risks of co-trimoxazole from the therapeutic point of view.
Infection 1987;15 Suppl 5():S231.
1987: Hartmut Lode; G Höffken; C Prinzing; P Glatzel; R Wiley; P Olschewski; B Sievers; D Reimnitz; Klaus Borner; Peter Koeppe
Comparative pharmacokinetics of new quinolones.
Drugs 1987;34 Suppl 1():21-5.
1987: Hartmut Lode
[Infection and septic shock. Antibiotic therapy].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1987;93():349-53.
1987: Hartmut Lode
Co-trimoxazole from the therapeutic viewpoint.
Infection 1987;15 Suppl 5():S222-6.
1987: Hartmut Lode; H Grothe; H Schäfer; B Kemmerich; G Ruckdeschel; H Ehret
[Clinical aspects and prognosis of Legionella infections].
Schriftenreihe des Vereins für Wasser-, Boden- und Lufthygiene 1987;72():15-25.
1986: F Keller; Karl Wagner; K Borner; B Kemmerich; Hartmut Lode; G Offermann; A Distler
Aminoglycoside dosage in hemodialysis patients.
Journal of clinical pharmacology 1986;26(8):690-5.
1986: R Stahlmann; Hartmut Lode
[Which factors are increasing the nephrotoxicity of aminoglucoside antibiotics?].
Deutsche medizinische Wochenschrift (1946) 1986;111(37):1409-14.
1986: K Borner; Hartmut Lode; G Höffken
Renal elimination of sulfo-ciprofloxacin, a new metabolite of ciprofloxacin.
European journal of clinical microbiology 1986;5(4):476.
1986: G Höffken; H Tetzel; P Koeppe; Hartmut Lode
The pharmacokinetics of ticarcillin, clavulanic acid and their combination.
The Journal of antimicrobial chemotherapy 1986;17 Suppl C():47-55.
1986: K Borner; Hartmut Lode; G Höffken; C Prinzing; P Glatzel; R Wiley
Liquid chromatographic determination of ciprofloxacin and some metabolites in human body fluids.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1986;24(5):325-31.
1986: Klaus Borner; G Höffken; Hartmut Lode; Peter Koeppe; C Prinzing; P Glatzel; R Wiley; P Olschewski; B Sievers; D Reinitz
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.
European journal of clinical microbiology 1986;5(2):179-86.
1986: K Borner; Hartmut Lode
[Biotransformation of selected gyrase inhibitors].
Infection 1986;14 Suppl 1():S54-9.
1985: G Höffken; H Tetzel; P Koeppe; Hartmut Lode
Pharmacokinetics and serum bactericidal activity of ticarcillin and clavulanic acid.
The Journal of antimicrobial chemotherapy 1985;16(6):763-71.
1985: Hartmut Lode; G Höffken; B Kemmerich
[Bacterial pneumonias].
Der Internist 1985;26(6):311-20.
1985: G Höffken; Klaus Borner; P D Glatzel; Peter Koeppe; Hartmut Lode
Reduced enteral absorption of ciprofloxacin in the presence of antacids.
European journal of clinical microbiology 1985;4(3):345.
1985: G Höffken; Hartmut Lode; C Prinzing; Klaus Borner; Peter Koeppe
Pharmacokinetics of ciprofloxacin after oral and parenteral administration.
Antimicrobial agents and chemotherapy 1985;27(3):375-9.
1985: F Keller; Hartmut Lode; G Offermann
Antimicrobial therapy in dialysis patients. II. Remaining antibiotics and antimicrobiologic agents.
Blood purification 1985;3(1-3):104-8.
1985: Hartmut Lode
Respiratory infection: the disease.
Clinical therapeutics 1985;7 Suppl A():1-18.
1985: Hartmut Lode; P D Glatzel
Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
Infection 1985;13 Suppl 1():S25-7.
1985: B Hampel; M Feike; Peter Koeppe; Hartmut Lode
Pharmacokinetics of temocillin in volunteers.
Drugs 1985;29 Suppl 5():99-102.
1985: B M Harnoss; C M Harnoss; K Borner; Hartmut Lode; P Koeppe
Biliary elimination of apalcillin in cholecystectomized patients.
Chemotherapy 1985;31(4):266-71.
1985: Klaus Borner; Hartmut Lode; B Hampel; M Pfeuffer; Peter Koeppe
Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.
Chemotherapy 1985;31(4):237-45.
1985: B M Harnoss; A Hirner; M Krüselmann; R Häring; Hartmut Lode
Antibiotic infection prophylaxis in gallbladder surgery--a prospective randomized study.
Chemotherapy 1985;31(1):76-82.
1985: B M Harnoss; Hartmut Lode
[Indications for and results of antibiotic prophylaxis].
Krankenpflege Journal 1985;23(1-2):11-3.
1984: F Keller; M Maiga; H H Neumayer; Hartmut Lode; A Distler
Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
European journal of drug metabolism and pharmacokinetics 1984;9(3):275-82.
1984: Hartmut Lode; A Elvers; P Koeppe; K Borner
Comparative pharmacokinetics of apalcillin and piperacillin.
Antimicrobial agents and chemotherapy 1984;25(1):105-8.
1984: R Lüthy; H Knothe; Hartmut Lode; H Stalder; W Stille
[Use of antibiotics in medical practice. Round Table].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1984;90 Pt 1():221-8.
1984: G Höffken; Hartmut Lode; P Koeppe; M Ruhnke; K Borner
Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver.
Chemotherapy 1984;30(1):7-17.
1983: B Kemmerich; Hartmut Lode; O Brückner
[Diagnosis and antibiotic treatment of infectious diseases in general practice. Results of an inquiry].
Deutsche medizinische Wochenschrift (1946) 1983;108(51-52):1943-7.
1983: Hartmut Lode; C M Harnoss; B Fangmann; A Loehr; J Wagner
[Septicemia. Etiology, epidemiology, clinical aspects and prognosis in 446 patients].
Deutsche medizinische Wochenschrift (1946) 1983;108(50):1908-14.
1983: Hartmut Lode; F Keller
[Antibiotic therapy in kidney failure].
Die Medizinische Welt 1983;34(47):1356-9.
1983: Hartmut Lode; R Grothe; H Schäfer; R Ruckdeschel
[Clinical and prognostic aspects of nosocomial Legionnaires pneumonias].
Praxis und Klinik der Pneumologie 1983;37 Suppl 1():925-6.
1983: B Kemmerich; A Schwarz; Hartmut Lode; G Offermann; T Dissmann
[Tuberculosis in terminal renal insufficiency].
Praxis und Klinik der Pneumologie 1983;37 Suppl 1():468-9.
1983: Hartmut Lode
Combination therapy with beta-lactam antibiotics.
The Journal of antimicrobial chemotherapy 1983;12(3):200-3.
1983: B Kemmerich; H Warns; Hartmut Lode; K Borner; P Koeppe; H Knothe
Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.
Antimicrobial agents and chemotherapy 1983;24(3):333-8.
1983: B Kemmerich; Hartmut Lode; K Borner; D Belmega; T Jendroschek; P Koeppe; G Goertz
Biliary excretion and pharmacokinetics of cefoperazone in humans.
The Journal of antimicrobial chemotherapy 1983;12(1):27-37.
1983: H Warns; Hartmut Lode; C M Harnoss; B Kemmerich; P Koeppe; J Wagner
Multiple dose pharmacokinetics and therapeutic results with ceftazidime.
The Journal of antimicrobial chemotherapy 1983;12 Suppl A():235-40.
1983: Hartmut Lode; V Madey; G Dzwillo; K Borner; P Koeppe
Serum bactericidal activity and kinetics of azlocillin and moxalactam after single and combined administration.
The Journal of antimicrobial chemotherapy 1983;11 Suppl B():121-6.
1983: Hartmut Lode; H Warns; B Kemmerich; H Knothe; P Koeppe
Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal flora.
European journal of clinical microbiology 1983;2(2):116-21.
1983: Hartmut Lode; Franz Daschner
[Gram-negative nosocomial infections. Epidemiology, causative agents, clinical aspects, trends].
Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis 1983;72(9):285-9.
1983: B Kemmerich; Hartmut Lode; G Belmega; T Jendroschek; K Borner; P Koeppe
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Antimicrobial agents and chemotherapy 1983;23(3):429-34.
1983: Klaus Borner; E Borner; Hartmut Lode; A Peters
Determination of cefmenoxime in human body fluids by high-performance liquid chromatography.
European journal of clinical microbiology 1983;2(1):17-21.
1983: Hartmut Lode; C M Harnoss
[Infection from the viewpoint of the infectiologist].
Beiträge zu Infusionstherapie und klinische Ernährung 1983;10():17-24.
1983: G Höffken; Hartmut Lode; H J Kessler
[Effect of doxycycline and isoconazole nitrate on human intestinal fungal flora].
Arzneimittel-Forschung 1983;33(2):273-6.
1982: B Hampel; Hartmut Lode; J Wagner; Peter Koeppe
Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage period.
Antimicrobial agents and chemotherapy 1982;22(6):1061-3.
1982: K Borner; Hartmut Lode; A Elvers
Determination of apalcillin and its metabolites in human body fluids by high-pressure liquid chromatography.
Antimicrobial agents and chemotherapy 1982;22(6):949-53.
1982: Hartmut Lode; G Höffken
[Pharmacokinetic aspects of oral therapy with antibiotics].
Der Internist 1982;23(11):624-31.
1982: G Höffken; Hartmut Lode
[Systemic antimycotic treatment].
Deutsche medizinische Wochenschrift (1946) 1982;107(38):1446-50.
1982: G Witkowski; Hartmut Lode; G Höffken; P Koeppe
Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination.
European journal of clinical microbiology 1982;1(4):233-7.
1982: Hartmut Lode
[Therapy of bronchopulmonary infections in adults].
Krankenpflege Journal 1982;20(7):14-9.
1982: Hartmut Lode; C M Harnoss; J Wagner; G Biamino; R Schröder
[Infectious endocarditis: clinical findings, therapy and course in 103 patients].
Deutsche medizinische Wochenschrift (1946) 1982;107(25):967-74.
1982: Hartmut Lode; H Schäfer; G Ruckdeschel
[Legionnaires' disease: prospective study of its incidence, clinical features and prognosis. (author's transl)].
Deutsche medizinische Wochenschrift (1946) 1982;107(9):326-31.
1982: Hartmut Lode; H Schäfer; R Schoeller; R Ruckdeschel
[Clinical picture of Legionnaires' disease (author's transl)].
Infection 1982;10 Suppl 2():S70-3.
1982: A Dalhoff; A E Gehl; W Gau; Hartmut Lode
Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
Chemotherapy 1982;28(6):444-53.
1982: A Dalhoff; A E Gehl; Hartmut Lode
Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
Chemotherapy 1982;28(5):381-9.
1981: G Höffken; Hartmut Lode
[Bronchopulmonary infection in adults. "Banal" infections, primary atypical pneumonia, bacterial pneumonias].
Die Medizinische Welt 1981;32(36):1302-5.
1981: T Jendroschek; G Belmega; Hartmut Lode; B Kemmerich; G Dzwillo; P Koeppe; J Wagner
[Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity].
Medizinische Klinik 1981;76(4):102-6, 70.
1981: Hartmut Lode; H Schäfer; R Ruckdeschel
[The new pneumonias].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1981;87():196-201.
1980: Hartmut Lode; B Kemmerich; G Gruhlke; G Dzwillo; P Koeppe; I Wagner
Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.
The Journal of antimicrobial chemotherapy 1980;6 Suppl A():193-8.
1980: Hartmut Lode; G Gruhlke; W Hallermann; G Dzwillo
Significance of pleural and sputum concentrations for antibiotic therapy of bronchopulmonary infections.
Infection 1980;Suppl 1():49-53.
1980: Hartmut Lode; R Stahlmann; G Dzwillo; P Koeppe
[Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
Arzneimittel-Forschung 1980;30(3):505-9.
1980: Hartmut Lode; W Tomas; P Koeppe; J Wagner
Clinical pharmacology of a new ureidopenicillin: Bay K 49999.
Chemotherapy 1980;26(2):81-90.
1980: Hartmut Lode; B Kemmerich; P Koeppe; D Belmega; H Jendroschek
Comparative pharmacokinetics of cefoperazone and cefotaxime.
Clinical therapeutics 1980;3(Spec Issue):80-8.
1979: Hartmut Lode; R Stahlmann; P Koeppe
Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.
Antimicrobial agents and chemotherapy 1979;16(1):1-6.
1979: Hartmut Lode
Penetration of antibiotics into the pleural fluid.
The Journal of antimicrobial chemotherapy 1979;5(2):122-4.
1979: D Kraft; Hartmut Lode
Elimination of ampicillin and gentamicin by hemofiltration.
Klinische Wochenschrift 1979;57(4):195-6.
1979: Hartmut Lode; P Köppe; R Stahlmann
[Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].
Infection 1979;7 Suppl 6():600-5.
1979: Hartmut Lode; U Huettemann; H Huckauf; H N Macha; R Aurich
Efficacy of reproterol assessed by the acetylcholine provocation test.
Respiration; international review of thoracic diseases 1979;38(5):280-8.
1979: W Siegenthaler; G Ahlert; H Knothe; G Linzenmeier; Hartmut Lode; R Lüthy; W Marget; J Schenk; C Simon; B Wiedemann
[Bacterial infections and possibility of oral antibiotic therapy with cephaclor].
Infection 1979;7 Suppl 6():515-36.
1978: G Höffken; Hartmut Lode; P Koeppe; H Wendt
[The effect of prednisolone on the resorption of amoxicillin].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1978;(84):967-8.
1978: Hartmut Lode; R Stahlmann; G Dzwillo; P Koeppe
[Pharmacokinetic comparative studies on the resorption of 3 new cephalosporins].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1978;(84):964-6.
1978: Hartmut Lode; K Grunert; B Kemmerich; P Koeppe
[Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
Advances in clinical pharmacology 1978;15():35-44.
1977: D Nolte; G Galgóczy; Hartmut Lode; A Mándi; H Matthys; E Stresemann
[A multi-centre study of reproterol, a bronchodilator (author's transl)].
Deutsche medizinische Wochenschrift (1946) 1977;102(16):619-23.
1977: Hartmut Lode; B Behn; H Langmaack; R Schröder
[Bacterial endocarditis. Clinical picture, treatment and course in 37 patients (author's transl)].
Deutsche medizinische Wochenschrift (1946) 1977;102(16):599-606.
1977: Hartmut Lode; K Niestrath; P Koeppe; H Langmaack
[Pharmacokinetics and clinical experience with 2 new penicillins: azlocillin and mezlocillin].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1977;83():1704-6.
1977: Hartmut Lode
[Indications for the monitoring of aminoglycoside serum concentrations in internal medicine (author's transl)].
Infection 1977;5(2):119-20.
1977: Hartmut Lode; U Niestrath; P Koeppe; H Langmaack
[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].
Infection 1977;5(3):163-9.
1976: Hartmut Lode; K Grunert; P Koeppe; H Langmaack
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
The Journal of infectious diseases 1976;134 SUPPL():S316-22.
1976: Hartmut Lode; K Grunert; P Koeppe; H Langmaack
[Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic].
Deutsche medizinische Wochenschrift (1946) 1976;101(36):1312-7.
1976: Hartmut Lode; K Grunert; P Koeppe; H Langmaack
[Pharmacokinetics and clinical experiences with a new aminoglycoside antibioticum: amikacin].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1976;82 Pt 2():1684-6.
1976: Hartmut Lode; B Altgelt; H Langmaack; R Schröder
[Bacterial endocarditis: clinical aspects, therapy and course forms in 36 patients].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1976;82 Pt 2():1063-4.
1976: Hartmut Lode; B Kemmerich
[Enzymatic quick determination of aminoglycoside antibiotics in serum].
International journal of clinical pharmacology and biopharmacy 1976;13(1):59-64.
1975: Hartmut Lode; B Kemmerich; P Koeppe; H Langmaack
[Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)].
Deutsche medizinische Wochenschrift (1946) 1975;100(42):2144-50.
1975: Hartmut Lode; B Kemmerich; P Koeppe
[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].
Antimicrobial agents and chemotherapy 1975;8(4):396-401.
1975: Hartmut Lode; B Kemmerich; H Langmaack
[Sisomycin--comparative pharmacokinetic studies and clinical experiences with a new aminoglycoside antibiotic].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1975;81():1646-8.
1975: Hartmut Lode
[Studies on the in vitro effects of cephalothin and gentamicin, alone and in combination, on proteus mirabilis and enterococci (author's transl)].
Infection 1975;3(2):83-8.
1975: Hartmut Lode; S Gebert; A Hendrischk
Comparative pharmacokinetics and clinical experience with a new cephalosporin-derivative: cefazolin.
Chemotherapy 1975;21(1):19-32.
1974: Hartmut Lode; P Janisch; G Küpper; H Weuta
Comparative clinical pharmacology of three ampicillins and amoxicillin administered orally.
The Journal of infectious diseases 1974;129(0):suppl:S156-68.
1974: Hartmut Lode; P Naumann
[The in vitro effects of cephalothin, gentamicin and their combination against Proteus mirabilis and Enterococci].
Advances in clinical pharmacology 1974;8():46-50.
1974: Hartmut Lode; P Janisch; G Küpper
[Clinical pharmacology of three ampicillins and amoxicillin by oral application].
Advances in clinical pharmacology 1974;7():35-9.
1974: Hartmut Lode; A Hendrischk; S Gebert
[Pharmacokinetics and therapeutic experiences with a new cephalosporin derivative: cefazoline].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1974;80():1541-3.
1973: P Naumann; Hartmut Lode; E Reintjens
[Combination therapy using penicillin. Methods of analysis and pharmacokinetics of oxacillin and ampicillin administered simultaneously].
Arzneimittel-Forschung 1973;23(2):218-25.
1973: Hartmut Lode; G Küpper
[Activity loss of antibiotics in infusion solutions].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1973;79():1438-40.
1973: Hartmut Lode; D Frisch; P Naumann
[Oral antibiotic therapy in gastrectomized patients].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1973;79():837-9.
1973: Hartmut Lode; G Küpper
[Inactivation of antibiotics in infusion solutions].
Infection 1973;1(3):151-6.
1972: Hartmut Lode; A Dalhoff; P Naumann
[Effects of cephalothin, gentamicin, and their combination on the bacterium Proteus mirabilis].
International journal of clinical pharmacology, therapy and toxicology 1972;6(4):346-53.
1972: Hartmut Lode; U Hüttemann; H Huckauf
[The effect of oral by administered theophylline on specific airway resistance in airway obstruction].
Arzneimittel-Forschung 1972;22(10):1788-91.
1972: Hartmut Lode; R Dreher; U Klemens
[Generalized so-called idiopathic amyloidosis. Clinical and pathologic-anatomical aspects].
Deutsche medizinische Wochenschrift (1946) 1972;97(26):1000-5.
1972: U Hüttemann; P Oswald; Hartmut Lode; H Huckauf
[Lung function studies in young apparently health cigarette smokers versus non-smokers].
Respiration; international review of thoracic diseases 1972;29(3):270-87.
1972: Hartmut Lode; U Hüttemann; C von Wolff
[The effect of endoscopic abdominal examinations on respiration].
Respiration; international review of thoracic diseases 1972;29(1):61-73.
1971: U Hüttemann; P Oswald; Hartmut Lode; H Huckauf
[Changes in pulmonary function of young adults as a result of long time cigarette smoking].
Deutsche medizinische Wochenschrift (1946) 1971;96(46):1791-3.
1971: U Hüttemann; G Kunkel; Hartmut Lode; E Hass
[The influence of laevomepromazine and prometazine on respiration in healthy subjects and patients with pulmonary emphysema].
Arzneimittel-Forschung 1971;21(10):1594-8.
1971: G Kunkel; Hartmut Lode
[Venous impurity and chronic intestinal diseases].
Schweizerische medizinische Wochenschrift 1971;101(9):319-25.
1971: Hartmut Lode; G Kunkel
[Use of polypropylen disposable syringes in blood-gas laboratory].
Zeitschrift für praktische Anästhesie und Wiederbelebung 1971;6(1):58-63.
1971: Hartmut Lode; U Hüttemann; C von Wolff
[Influence of abdominal endoscopic examinations on respiration].
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1971;77():1114-8.
1970: Hartmut Lode
[Antibiotic treatment of broncho-pulmonary infections].
Praxis der Pneumologie vereinigt mit Der Tuberkulosearzt 1970;24(2):65-81.
1969: Hartmut Lode; G Kunkel; U Hüttemann
[Paget's disease of the spine with partial paraplegia].
Deutsche medizinische Wochenschrift (1946) 1969;94(11):539-41 passim.